On May 30, the Massey TBI Grand Challenge teams who were selected to move on in the competition will pitch their research and innovations before the “Wolverines”—an interdisciplinary panel comprised of clinicians, entrepreneurs, Department of Defense representatives and business development experts.
On April 25, the Kahn Pediatric Critical Care Grand Challenge teams who were selected to move on in the competition will pitch their research and innovations before the “Wolverines”—an interdisciplinary panel comprised of clinicians, entrepreneurs, children’s health specialists and business development experts.
The first half of this free, virtual workshop will focus on the NSF Partnerships for Innovation (PFI) program, and the second half will cover the NSF Grant Opportunities for Academic Liaison with Industry (GOALI) program. This workshop is ideal for researchers, faculty members, postdocs, students, and entrepreneurs interested in leveraging their research for real-world impact or seeking to leverage industry partnerships to advance their research and accelerate scientific progress.
The NSF PFI component of the workshop will equip researchers and innovators with the tools and skills to bridge the gap between research and the marketplace. Participants will gain expertise in Technology translation and development, Industry collaboration, Proof-of-concept development, and Entrepreneurial skills.
Turning discoveries into practical solutions: Learn how to take your research and develop it into something useful for the real world.
Working together to succeed: Develop skills to collaborate effectively with different organizations and people to bring your ideas to life.
Building your innovation toolkit: Gain the knowledge and skills needed to navigate the process of bringing your technology to market.
The NSF GOALI component of the workshop will empower researchers to navigate the landscape of successful collaboration between academia and industry. Participants will gain insights into Collaborative research, Industry engagement, and Project management.
Teaming up for research: Learn how to work effectively with companies to advance your research and achieve shared goals.
Understanding industry needs: Gain insights into what companies are looking for and how your research can benefit them.
Managing research collaborations: Develop skills to plan, execute, and successfully complete research projects with industry partners.
Now that you’ve completed an I-Corps course and conducted 20-30 customer discovery interviews, what’s next in your customer discovery and commercialization journey? Non-dilutive SBIR/STTR funding may be a consideration. The government’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs make over $4 billion in high-risk, non-dilutive capital available to innovative small companies annually, but you have to propose a clearly defined R&D project that helps de-risk your technology in preparation for commercialization.
This virtual SBIR Webinar will provide an overview of the SBIR/STTR programs and how you can leverage your knowledge gained from customer discovery to build a compelling SBIR/STTR proposal. In this interactive workshop, we’ll learn how to use data from customer discovery to come up with 1-3 clearly defined Technical Objectives related to product development for a Phase I application. The SBIR Webinar will also go over how to use data from market research and customer discovery to determine your quantitative metrics for success.
Megan joined BBC Entrepreneurial Training & Consulting as a Principal Consultant in 2019 with a wealth of experience in leading biological technologies on the path to commercialization. As CEO of FibrosIX Inc., a Michigan company developing compounds for the treatment or prevention of fibrosis-related disorders, Megan was involved in all aspects of planning and operation of the company. This included writing an SBIR grant proposal, which was awarded from the National Cancer Institute. Her prior experience includes serving as an Entrepreneur in Residence for Michigan State University’s Spartan Innovations where she assisted MSU researchers in translating their technologies into startup businesses. While at MSU, she managed the launch of two startups and assisted in preparation of both NIH and NSF SBIR proposals. A former Research Associate of the Scripps Research Institute, Megan received a B.S degree from the University of Massachusetts Amherst and a PhD from Boston University.
BBCetc is nationally recognized for its success in helping emerging companies win SBIR/STTR funding and use it strategically to propel growth. BBCetc’s Michigan clients have been awarded over $406 million in funding since 2002. The company was recently named a 2020 Tibbetts award winner as well as one of 50 “Michigan companies to watch” by Michigan Celebrates Small Business.
Activate is the premier program for scientists on a mission. This two-year fellowship provides early-stage hard-tech science entrepreneurs $100K in research funding, yearly stipends of up to $110K, intensive entrepreneurial training, mentorship, networking, and other benefits.
Join us to:
Learn how the Activate Fellowship can support you directly after I-Corps
Find out project and applicant eligibility criteria, and how to apply for the fellowship
Hear a Fellow’s journey and perspective on the Activate Fellowship
Speaker: Patrick Sullivan, Activate Anywhere Cohort 2023 Fellow
Applications open this fall. Learn more about the Activate Fellowship here.
Now that you’ve completed an I-Corps course and conducted 20-30 customer discovery interviews, what’s next in your customer discovery and commercialization journey? This National I-Corps Webinar will provide an overview of the NSF National I-Corps Teams program and allow ample time for Q&A.
Learn what the NSF National I-Corps Teams program is and how it can move your team forward
Develop a basic understanding of application requirements for the NSF National I-Corps Teams program
Receive guidance on putting your application together
Identify the people you want/need to be on your NSF National I-Corps team
Understand what to expect during the application process and the program itself
This is a one-hour synchronous National I-Corps Webinar on Zoom. Experts in applying for the NSF I-Corps National Teams program and $50,000 grant will give an overview of the program. The session will end with 30 minutes of open Q&A.
With each passing day, AI technologies play a more and more prominent role in our lives. AI is transforming fields including healthcare, business, science, art, technology, transportation, and more. It is reaching into nearly every aspect of our broader society. Ensuring that we are developing, deploying, and evaluating AI applications ethically and responsibly is imperative — as is providing equal access to these tools.
Please join the Weil Institute on March 12 as we launch the 2024 Massey TBI Grand Challenge. Made possible through the generous support of the Joyce and Don Massey Family Foundation, the Massey TBI Grand Challenge supports high-risk research and innovations addressing the initial "golden hours" of care after severe traumatic brain injury.
Up to $800,000 is available this year to fund device, diagnostic, therapeutic and health information technology solutions.
To be considered eligible for funding, you and/or a team member must attend the March 12 kickoff event. The Grand Challenge is open to all U-M faculty and staff. Participants from outside organizations are welcome to collaborate and apply, provided one PI on their team is from the University of Michigan.
Matthew E. Fink, MD
Dr. Fink is the Assistant Dean for Clinical Affairs and the Louis and Gertrude Feil Professor and Chair of Neurology at New York Presbyterian/Weill Cornell Medicine. Prior to joining the faculty of New York-Presbyterian/Weill Cornell, Dr. Fink served as president and chief executive officer of Beth Israel Medical Center in New York, as well as chairman of its Barbara and Alan Mirken Department of Neurology, director of the Comprehensive Stroke Center and co-director of the Hyman-Newman Institute for Neurology and Neurosurgery. He also served as professor of clinical neurology and clinical medicine at the Albert Einstein College of Medicine of Yeshiva University.
Dr. Fink is board certified in internal medicine, neurology, critical care medicine, vascular neurology and neurocritical care. He was a founding member and chairman of the Critical Care Section of the American Academy of Neurology and the Research Section for Neurocritical Care of the World Federation of Neurology. He is a past president of the New York Neurological Society and was recently elected to fellowship in both the American Academy of Neurology and the American Heart Association. Throughout his career, Dr. Fink has been involved in the education and training of students, residents and fellows in the field of stroke and critical care neurology, as well as an active participant in clinical research within this field. He has lectured widely and published many research and clinical articles.
October 19, 2023 | 8AM - 4PM | Junge Family Champions Center
DARPA is a federal funding agency that creates capabilities. To do this, the agency has created a unique approach within the government which is to look for ways to say "yes." The result has been some remarkable technological advances.
Weil Institute’s Model Performance Diagnostics tool to be featured at U-M Innovation Partnerships annual Celebrate Invention event!
Wolf Creek XVII will take place June 14-17 at the historic Michigan Union Building located in downtown Ann Arbor, Michigan. Together with sharing insightful discussions and looking into the future of CPR research, we also have various activities planned throughout Ann Arbor.
This event is by invitation only.
The Biointerfaces Institute hosts Dr. H. Uri Saragovi who will present "Academic Translation: Therapeutic Targets and Therapeutic Agents for Neurodegeneration and Cancer".
The Massey TBI Grand Challenge is a powerful funding avenue for multidisciplinary critical care research teams that supports the development of diagnostic, device, therapeutic, or health IT solutions addressing the initial ‘golden hours’ of care after severe traumatic brain injury.
Join the Weil Institute on March 9 as we launch the 2023 Grand Challenge with an informative kickoff session! This is an excellent opportunity for those interested in participating to network and learn more about the Grand Challenge process.
While this is a hybrid event, we strongly recommend guests attend in-person if able.
Meet with mentors in medicine, engineering, and IP and commercialization during the Wolverine Wrangle—a collaborative speed networking session designed to give competitors the opportunity to connect with likeminded researchers, identify potential collaborators, pick the brains of previous awardees and interact with industry leaders, researchers, and potential PIs to further develop and refine ideas prior to submitting a proposal.
"Critically ill COVID-19 subphenotypes and differential treatment effects"
Presenter: Manu Shankar-Hari, MD, MBBS, MSc
Time: 11:00am-12:00pm
Link: https://umich.zoom.us/j/93154701819?pwd=UzJlb2UyZnkwbDIrZm9CdUt0eXV0QT09
Meeting ID: 931 5470 1819
Passcode: 010764
Conference is also available via the QR code above. Scan with your smartphone’s camera to access.
Dr. Manu Shankar-Hari is Professor in Critical Care Medicine and NIHR Clinician Scientist at King’s College London. His research explores ways to improve outcomes in adult critically ill patients with sepsis and with ARDS by linking the illness immunobiology to interventional trial design.
Dr. Shankar-Hari’s lab has two focused research themes:
The immunobiology part of his laboratory utilises flow cytometry, mass cytometry, a cultured cell, transcriptomics, epigenetics and bioinformatics approaches to study adaptive immune system changes in sepsis and ARDS.
The epidemiology and trial design part of his laboratory uses cohort studies, systematic reviews and large datasets to explore treatment response mechanisms, using principles of causality, modifiable determinants and dominant mechanisms in sepsis and ARDS related critical illness.
WHO
Michael Puskarich, MD
(Associate Professor and Director of Research, Department of Emergency Medicine, University of Minnesota and Hennepin County Medical Center)
WHEN
February 3, 2023 | 10:00 - 11:00 AM
WHERE
North Campus Research Complex Building 10, South Atrium
LUNCH WILL BE PROVIDED
Michael Puskarich, MD, MSCR
Associate Professor of Emergency Medicine, University of Minnesota
Dr. Puskarich is a practicing emergency physician and acute care clinical trialist who has been on the leading edge of COVID clinical trials since the onset of the pandemic.
He rapidly launched two multicenter trials in both the inpatient and outpatient settings repurposing losartan to modulate RAAS, opening to enrollment in April 2020 and completed within the first year of the pandemic. With University of Michigan investigators, he submitted one of the earliest platform trial proposals to the NIH in the spring of 2020. Building on his outpatient trial, he assisted University of Minnesota COVID-OUT investigators in completion of a decentralized factorial trial of repurposed putative outpatient treatments.
Dr. Puskarich has held various investigator and leadership roles in the REMAP-CAP RAAS domain, ACTIV-4a, ACTIV-4b, ACTIV-4d, C3PO, the CDC-RECOVER surveillance network, and currently serves in Hennepin international coordinating center leadership within the STRIVE network.
With a ground-level real-time perspective, he will discuss the accelerating effect the pandemic had on acute care clinical trial design and conduct using examples from the past 3 years, including operational advances in hands-off teleresearch and decentralized trials, navigation of ethical, regulatory, and public relations challenges, effects of network consolidation, increasing prevalence of adaptive and platform trials, and the statistical approaches and reporting helping push the acute care clinical trial literature forward.
Mark Kahn and the Weil Institute for Critical Care Research and Innovation at the University of Michigan are releasing an RFP in December 2022 for research into innovative solutions in pediatric critical care. We are asking teams to develop diagnostic, device, therapeutic, or health information technology solutions that address current gaps in the monitoring, diagnosis and treatment of critically ill and/or injured children.
The annual Summit (previously known as the annual Symposium) is the largest annual data science and AI event on campus. The event brings together the U-M data science and AI research community and their external collaborators to build research vision and collaboration. It also showcases the breadth and depth of U-M data science and AI research, from theory and methodology development to the transformative use of data and AI to address scientific and societal challenges in all domains.
The event is free for all attendees (U-M faculty, staff, and trainees, as well as industry, government and community members).
Abstracts due by 11:59 pm, Sept. 23, 2022
On October 25 (Tues.) at 10 AM, the Weil Institute will be holding a virtual info session on all things Grand Challenge-related. This is an excellent opportunity for teams to learn about the Grand Challenge process ahead of the kickoff and discover the resources we have available to them.
Conference link (opens 10/25): https://umich.zoom.us/j/99902623892
Time: 10:00 am - 12:00 pm EST
You will not need to register for this session—simply drop on by! Teams are only required to attend the December 8 kickoff to be considered for funding.
Please join us on Friday, October 21 as the Weil Institute continues our Visiting Scholar Seminar series, welcoming Dr. Lars Larsson, Professor of Neurophysiology from Sweden's Karolinska Institute.
Dr. Larsson, a world expert on skeletal muscle dysfunction in critical illness, will be presenting from 11am-12pm in the Frankel Cardiovascular Center's Danto Auditorium. Registration is available at the link below, and lunch will be provided at the event.
We look forward to seeing you there!
The Weil Institute and Michigan Medicine are thrilled to welcome Dr. Renaud Tissier from the National Veterinary School of Alfort (Ecole Nationale Vétérinaire d'Alfort). Dr. Tissier will be presenting “Lung-conservative liquid ventilation: a way for ultra-rapid cooling in the early phase after resuscitation”. Details and registration are below.
For questions about the event, please contact Sue Wozniak at swo@med.umich.edu.
May 2, 2022
12-1 PM
MCHC Auditorium (UH South, room F2305)
NOTE: Food and beverages are not permitted in the auditorium.
Renaud Tissier, DVM, PhD, is Professor of Pharmacology and Toxicology, as well as vice-dean for research at Ecole Nationale Vétérinaire d'Alfort. He obtained his PhD in 2003 at Université Paris Sud. He has been coordinator of several research grants and published more than 100 scientific articles in peer-reviewed international reviews. He has given more than 100 conferences in national and international congresses. Today, he is leading a research group working on the effect of hypothermia in post-cardiac arrest syndrome.
The 2022 Massey TBI Grand Challenge kicks off on March 3, and it's going to be bigger and better than ever. MCIRCC is thrilled to announce that, this year, we will have a grand total of $1 MILLION available to fund multidisciplinary teams proposing high-risk ideas and innovations addressing the golden hours of traumatic brain injury.
But that’s not all that’s new in 2022. Visit the official event page to see the latest.
The European Healthcare Design “Future Hospital 2050” is a 3-day global seminar examining future innovation in surgical care, critical care and emergency care.
Panels of leading global experts will look at the main drivers expected to shape the future hospital, from AI and medtech to climate and the workforce. Each 90-minute episode will focus on a different “hot core” area and feature an international panel of leading clinicians, planners, designers and innovators to discuss the key issues. Case study examples will also be shared.
Among the panelists for this year are Ben Bassin, MD (Emergency Medicine) and Cemal Sozener, MD (Emergency Medicine).
The Joyce Massey TBI Summit brings together TBI experts from across the country to present their current research, discuss the future of the field and identify important barriers to improving outcomes. Since the inaugural Summit, we have welcomed the nation’s leading authorities as well as those who are just beginning their journey—a combination that opens the door to new ideas and possibilities.
The Summit is made possible through the generosity of the Joyce and Don Massey Family Foundation. Their vision for improving the treatment and care of TBI patients continues to motivate researchers across the globe.
Dr. Michael Filbin, Director of Clinical Research in Emergency Medicine at Massachusetts General Hospital, presents his molecular phenotyping work in sepsis and COVID-19.
The Division of Pulmonary and Critical Care Medicine is pleased to present a research talk by visiting professor Fernando Zampieri, M.D., who will be discussing the results of the BaSICS trial as well as some yet-to-be published analyses on the impact of pre-enrollment fluid.
Ask the Experts: A Biomedical Innovation Forum is a virtual event hosted by Fast Forward Medical Innovation, in partnership with the U.S. Economic Development Administration, where a panel of experts from the life science investment community will provide insight on trends within the industry and reveal investment criteria considered when evaluating emerging technologies. The panel will be followed by a virtual poster session highlighting projects from the FFMI Hub at the University of Michigan. Wednesday, June 16 12:00pm-2:00pm
CLICK HERE for more information and to register.
Precision Health at the University of Michigan (U-M) invites you to engage with two outstanding Scholars who have been funded by Precision Health to develop their research.
Arun Subramaniyan, BE, MS (graduate student, College of Engineering): “Accelerated Systems for Precision Health”
Alyse Krausz, BS, MS (graduate student research assistant, Biomedical Engineering): “ A Variable-height Microfluidic Device for Multiplexed Immunoassay Analysis of Traumatic Brain Injury Biomarkers”
You'll hear more about their work and how they used Precision Health resources in their innovative projects.
Arun Subramaniyan is a fifth-year Ph.D. student at the University of Michigan, advised by Prof. Reetuparna Das. His dissertation research focuses on developing efficient algorithms and customized computing systems for precision health. He is a 2018 Precision Health Scholar. His work has also been recognized by Rackham's International Students Fellowship and the IEEE Micro Top Picks Award, awarded annually to some of the most significant research papers in computer architecture.
Alyse Krausz graduated from The Ohio State University in 2016 with a B.S. in Biomedical Engineering. She is currently finishing her PhD in Biomedical Engineering in the lab of Professor Mark Burns and plans to defend her dissertation in July. Alyse's research focuses on the development of point-of-care microfluidic technologies. She was previously a Microfluidics in Biomedical Sciences Training Program (MBSTP) fellow, and in 2019, she received a Precision Health Scholars Award for her work applying microfluidics to the quantification of traumatic brain injury biomarkers.
Tuesday, May 25 at 1pm
CLICK HERE for more information and to register.
Jen Baird and her team at FifthEye were just granted De Novo classification by FDA for their Analytic for Hemodynamic Instability (AHI). AHI can continuously monitor any patient with an electrocardiogram (ECG) for hemodynamic instability. Come hear all about their success, what comes next for getting AHI to market, and what they've learned about working with FDA thus far!
The Massey TBI Grand Challenge is a powerful funding avenue for multidisciplinary critical care research teams. Made possible by a generous gift from the Joyce and Don Massey Family Foundation, the TBI Grand Challenge supports the development of diagnostic, device, therapeutic, or health IT solutions that address the initial ‘golden hours’ of care after severe traumatic brain injury.
This year, MCIRCC is thrilled to present our largest award amount to date: Up to $900,000 is available in 2021 to help teams take their ideas from research to impact. But achieving victory won’t be easy: The Grand Challenge process culminates in the “Wolverine Den”, where teams who make it through the first two rounds of judging will then pitch their research before an expert panel of neurointensivists, clinicians, entrepreneurs, business development and Department of Defense experts.
NOTE: To be considered for funding, you must attend the Grand Challenge Kick-off event.
The Michigan Institute for Data Science (MIDAS) is holding its annual symposium November 10-11.
Christopher E. Gillies, PhD - Assistant Research Scientist
Research Talk Session 2 features MCIRCC’s own Christopher E. Gillies, PhD, who will present “An end-to-end deep learning system for rapid analysis of the breath metabolome with applications in critical care illness and beyond."
The presentation will begin around 9:20 AM on November 11.
To learn more and register for the event, please go to https://midas.umich.edu/2020-symposium/.
